FR3071512B1 - Signatures moleculaires de trois sous-populations de fibroblastes dermiques et equivalent de derme comprenant une de ces sous-populations - Google Patents

Signatures moleculaires de trois sous-populations de fibroblastes dermiques et equivalent de derme comprenant une de ces sous-populations Download PDF

Info

Publication number
FR3071512B1
FR3071512B1 FR1759026A FR1759026A FR3071512B1 FR 3071512 B1 FR3071512 B1 FR 3071512B1 FR 1759026 A FR1759026 A FR 1759026A FR 1759026 A FR1759026 A FR 1759026A FR 3071512 B1 FR3071512 B1 FR 3071512B1
Authority
FR
France
Prior art keywords
populations
sub
fibroblast
dermal fibroblasts
molecular signatures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1759026A
Other languages
English (en)
Other versions
FR3071512A1 (fr
Inventor
Valerie Haydont
Daniel Asselineau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1759026A priority Critical patent/FR3071512B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Priority to PCT/EP2018/076347 priority patent/WO2019063731A1/fr
Priority to JP2020518055A priority patent/JP7399083B2/ja
Priority to CN201880063540.0A priority patent/CN111164223B/zh
Priority to EP18773228.4A priority patent/EP3688192B1/fr
Priority to US16/650,258 priority patent/US20210371925A1/en
Publication of FR3071512A1 publication Critical patent/FR3071512A1/fr
Priority to JP2021202527A priority patent/JP2022031351A/ja
Application granted granted Critical
Publication of FR3071512B1 publication Critical patent/FR3071512B1/fr
Priority to JP2023188579A priority patent/JP2024003103A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656Adult fibroblasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

La présente invention a pour objet l'utilisation d'un produit d'expression d'au moins un gène choisi dans le groupe constitué des gènes UCP2, et FGF9 et éventuellement des gènes COL11A1 et ACAN, éventuellement en combinaison avec un produit d'expression du gène KLF9, comme marqueur pour identifier in vitro un fibroblaste dermique comme étant un fibroblaste papillaire, un fibroblaste réticulaire ou un fibroblaste de la jonction dermo-hypodermique (FJDH).
FR1759026A 2017-09-28 2017-09-28 Signatures moleculaires de trois sous-populations de fibroblastes dermiques et equivalent de derme comprenant une de ces sous-populations Active FR3071512B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR1759026A FR3071512B1 (fr) 2017-09-28 2017-09-28 Signatures moleculaires de trois sous-populations de fibroblastes dermiques et equivalent de derme comprenant une de ces sous-populations
JP2020518055A JP7399083B2 (ja) 2017-09-28 2018-09-27 真皮繊維芽細胞の3種の亜集団の分子シグネチャー及びこれらの亜集団のうちの1種を含む真皮等価物
CN201880063540.0A CN111164223B (zh) 2017-09-28 2018-09-27 真皮成纤维细胞的三个亚群的分子标签和包括这些亚群之一的真皮等同物
EP18773228.4A EP3688192B1 (fr) 2017-09-28 2018-09-27 Signatures moléculaires de trois sous-populations de fibroblastes dermiques et équivalent dermique comprenant une de ces sous-populations
PCT/EP2018/076347 WO2019063731A1 (fr) 2017-09-28 2018-09-27 Signatures moléculaires de trois sous-populations de fibroblastes dermiques et équivalent dermique comprenant une de ces sous-populations
US16/650,258 US20210371925A1 (en) 2017-09-28 2018-09-27 Molecular signatures of three sub-populations of dermal fibroblasts and dermal equivalent comprising one of these sub-populations
JP2021202527A JP2022031351A (ja) 2017-09-28 2021-12-14 真皮繊維芽細胞の3種の亜集団の分子シグネチャー及びこれらの亜集団のうちの1種を含む真皮等価物
JP2023188579A JP2024003103A (ja) 2017-09-28 2023-11-02 真皮繊維芽細胞の3種の亜集団の分子シグネチャー及びこれらの亜集団のうちの1種を含む真皮等価物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1759026A FR3071512B1 (fr) 2017-09-28 2017-09-28 Signatures moleculaires de trois sous-populations de fibroblastes dermiques et equivalent de derme comprenant une de ces sous-populations
FR1759026 2017-09-28

Publications (2)

Publication Number Publication Date
FR3071512A1 FR3071512A1 (fr) 2019-03-29
FR3071512B1 true FR3071512B1 (fr) 2022-02-25

Family

ID=61027846

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1759026A Active FR3071512B1 (fr) 2017-09-28 2017-09-28 Signatures moleculaires de trois sous-populations de fibroblastes dermiques et equivalent de derme comprenant une de ces sous-populations

Country Status (6)

Country Link
US (1) US20210371925A1 (fr)
EP (1) EP3688192B1 (fr)
JP (3) JP7399083B2 (fr)
CN (1) CN111164223B (fr)
FR (1) FR3071512B1 (fr)
WO (1) WO2019063731A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3083246B1 (fr) * 2018-06-29 2023-12-08 Oreal Modeles cellulaires et tissulaires comprenant des fibroblastes de la jonction dermo-hypodermique et ses applications
CN113215098B (zh) * 2021-06-04 2023-02-24 安徽医科大学第一附属医院 一种低成本原代小鼠脾脏网状成纤维细胞体外分离和培养方法
CN113355278A (zh) * 2021-06-29 2021-09-07 安徽医科大学第一附属医院 Ⅰ型干扰素受体基因敲除小鼠脾脏网状成纤维永生化细胞系的培养方法及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980001350A1 (fr) 1978-12-26 1980-07-10 Massachusetts Inst Technology Substitut de peau
US4604346A (en) 1984-10-09 1986-08-05 Massachusetts Institute Of Technology Skin-equivalent prepared by the use of punch biopsy
FR2612939B1 (fr) 1987-03-26 1989-06-23 Cird Equivalent de peau
FR2612938B1 (fr) 1987-03-26 1989-06-23 Cird Procede d'obtention d'un equivalent de peau et equivalent de peau correspondant
IL95429A (en) 1989-09-15 1997-09-30 Organogenesis Living tissue equivalents comprising hydrated collagen lattice and a collagen gel and their production
USRE35399E (en) 1990-04-24 1996-12-10 Eisenberg; Mark Composite living skin equivalents
FR2665175B1 (fr) 1990-07-27 1993-12-31 Rosdy Martin Equivalent d'epiderme, son procede d'obtention et son utilisation.
FR2667246A1 (fr) 1990-10-02 1992-04-03 Imedex Biomateriau a base de collagene et des applications.
FR2689904B1 (fr) 1992-04-08 1994-12-16 Martin Rosdy Test de bronzage épidermique in vitro.
FR2743817B1 (fr) 1996-01-23 1998-03-13 Oreal Equivalent de peau comprenant des cellules de langerhans
JP2000508922A (ja) * 1996-04-26 2000-07-18 ケース ウエスターン リザーブ ユニバーシティ 間葉幹細胞を用いる皮膚再生
FR2903702B1 (fr) * 2006-07-13 2012-10-19 Oreal Equivalent d'epiderme capable de se pigmenter obtenu a partir de cellules de la matrice, procede de preparation et utilisation
FR2940611B1 (fr) * 2008-12-30 2012-01-13 Oreal Association de monosaccharides et d'adenosine et son utilisation en cosmetique
EP2783212B1 (fr) * 2011-11-25 2016-10-05 Chanel Parfums Beauté Nouveaux marqueurs de fibroblastes réticulaires et papillaires et utilisations de ceux-ci
SG11201700095SA (en) * 2014-07-09 2017-02-27 Sanford Burnham Med Res Inst Methods and compositions to modulate hair growth

Also Published As

Publication number Publication date
EP3688192B1 (fr) 2024-05-01
JP2024003103A (ja) 2024-01-11
CN111164223A (zh) 2020-05-15
EP3688192C0 (fr) 2024-05-01
CN111164223B (zh) 2024-06-21
US20210371925A1 (en) 2021-12-02
WO2019063731A1 (fr) 2019-04-04
JP2022031351A (ja) 2022-02-18
FR3071512A1 (fr) 2019-03-29
EP3688192A1 (fr) 2020-08-05
JP2020534852A (ja) 2020-12-03
JP7399083B2 (ja) 2023-12-15

Similar Documents

Publication Publication Date Title
FR3071512B1 (fr) Signatures moleculaires de trois sous-populations de fibroblastes dermiques et equivalent de derme comprenant une de ces sous-populations
BR112015009780A2 (pt) composição de xampu compreendendo polímeros de silicone de baixa viscosidade
EP3296910A3 (fr) Gestion de logiciel intrusif
CN107397757A8 (zh) 润滑剂制剂
BR112016020026A8 (pt) Sistema de serviço no campo de coletar leite materno humano ou no campo da drenagem médica, unidade base, meio de dados móvel de um sistema de serviço e produto
BR112012021269A2 (pt) composição modular.
FR3061017B1 (fr) Composition cosmetique comprenant de la gelee royale d'abeille noire d'ouessant
BR112014029743A8 (pt) método e sistema de comutação de nó de serviço
MX2019013327A (es) Formulación para administración ocular de fármacos.
FR3079142B1 (fr) Composition veterinaire comprenant de la superoxyde dismutase et au moins un hydrolysat de proteines riche en peptides bioassimilables
MX2023011670A (es) Formulacion estable de anticuerpo contra el receptor de oncostatina m (osmr).
ATE535552T1 (de) Phenantrolinhaltige komplexe
FR3029787B1 (fr) Composition nettoyante a base a base d'un polyethylenegycol, d'un polyether ester et d'un agent de suspension polymerique
GB202004168D0 (en) Information processing system, and platform
FR2920301B1 (fr) Utilisation d'une association hesperidine et microorganisme pour le traitement de la secheresse des matieres keratiniques.
MA38871B2 (fr) Complexe lubrifiant pour la bouche
MX2022016500A (es) Sistema y metodo de retroalimentacion del usuario.
PH12019502209A1 (en) Antimicrobial personal cleansing compositions
MX2021005158A (es) Portador y protector de la mucosa bucal.
FR3065648B1 (fr) Applicateur d'un produit de traitement cosmetique de la peau ou des levres
FR3033565B1 (fr) Precatalyseur a base de fer et son utilisation dans la polymerisation d'olefines
Lee et al. The Effects of Emotional Intelligence and Service Flexibility on Customer Contact Center Employee Satisfaction and Performance
FR3078259B1 (fr) Utilisation cosmetique d'un extrait de sarriette citronnee comme agent anti-pollution
TH186290S (th) โทรศัพท์มือถือ
TH186284S (th) โทรศัพท์มือถือ

Legal Events

Date Code Title Description
PLSC Publication of the preliminary search report

Effective date: 20190329

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8